Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
325,239
-
Shares change
-
0
-
Total reported value, excl. options
-
$2,082
-
Price
-
$0.006400
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2025
As of 30 Jun 2025 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 325,239 shares of stock of the company.
Largest 1 holders included Birchview Capital, LP.
This table shows 1 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.